In this episode, we explore how data, AI, and capital are transforming the life sciences industry as 2026 begins. We start with Accenture and Salesforce's new AI-powered life sciences cloud, designed to streamline operations and improve decision-making. Next, we discuss Alexandra Beneville's appointment at Phreesia, enhancing their life sciences content strategy. We then highlight a company's expanded AI partnership to accelerate clinical development. Eytan Ellenberg delves into the complexities of drug causality, while Haisco Pharmaceutical's AirNexis spinout targets the Western market with a new respiratory treatment. We also cover a study favoring risk-based breast cancer screening over traditional methods. Finally, we examine the $4.9 billion funding surge in biotech as the J.P. Morgan Healthcare Conference approaches.

Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture.

As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics.

Start your VoiceStream free trial today!